Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Citi
UBS
Baxter
QuintilesIMS
Boehringer Ingelheim
Cipla
Medtronic
Covington
Merck

Generated: February 25, 2018

DrugPatentWatch Database Preview

Doxazosin mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for doxazosin mesylate and what is the scope of doxazosin mesylate freedom to operate?

Doxazosin mesylate
is the generic ingredient in three branded drugs marketed by Pfizer, Accord Hlthcare, Actavis Elizabeth, Apotex, Dava Pharms Inc, Genpharm, Heritage Pharma, Idt Australia Ltd, Ivax Sub Teva Pharms, Mylan, Nesher Pharms, Pliva, Teva, Watson Labs Inc, Yaopharma Co Ltd, and Zydus Pharms Usa Inc, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for doxazosin mesylate. Thirty-four suppliers are listed for this compound.
Pharmacology for doxazosin mesylate
Medical Subject Heading (MeSH) Categories for doxazosin mesylate

US Patents and Regulatory Information for doxazosin mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 208719-004 Jul 7, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Elizabeth DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 075574-001 Oct 18, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Accord Hlthcare DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 202824-002 Jun 11, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Genpharm DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 075466-002 Oct 18, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 075580-004 Oct 18, 2000 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Idt Australia Ltd DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 075432-003 Oct 18, 2000 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Genpharm DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 075466-001 Oct 18, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Heritage Pharma DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 205210-001 Feb 13, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa Inc DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 208719-002 Jul 7, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Inc DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 075426-004 Oct 18, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for doxazosin mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer CARDURA XL doxazosin mesylate TABLET, EXTENDED RELEASE;ORAL 021269-002 Feb 22, 2005 ➤ Sign Up ➤ Sign Up
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-003 Nov 2, 1990 ➤ Sign Up ➤ Sign Up
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-004 Nov 2, 1990 ➤ Sign Up ➤ Sign Up
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-001 Nov 2, 1990 ➤ Sign Up ➤ Sign Up
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-002 Nov 2, 1990 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Julphar
Healthtrust
Chinese Patent Office
Fuji
Johnson and Johnson
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot